Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9266)
All Articles published online
|
Publishing Process of This Article
|
Apr 27, 2021 (publication date) through Feb 1, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Alamoudi JA, Li W, Gautam N, Olivera M, Meza J, Mukherjee S, Alnouti Y. Bile acid indices as biomarkers for liver diseases I: Diagnostic markers. World J Hepatol 2021; 13(4): 433-455 [PMID: 33959226 DOI: 10.4254/wjh.v13.i4.433] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Alamoudi JA, Li W, Gautam N, Olivera M, Meza J, Mukherjee S, Alnouti Y. Bile acid indices as biomarkers for liver diseases I: Diagnostic markers. World J Hepatol 2021; 13(4): 433-455 [PMID: 33959226 DOI: 10.4254/wjh.v13.i4.433] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i4/433.htm |
| Number | Citing Articles |
| 1 |
Huiping Zhou, Yi Huang, Chen Chen, Meiyi Song, Phillip.B. Hylemon. Gut Microbiome and Bile Acid Metabolism in Liver Disease: Mechanisms, Clinical Implications, and Therapeutic Opportunities. Pharmacological Reviews 2026; : 100120 doi: 10.1016/j.pharmr.2026.100120
|
| 2 |
J. Jose Corbalan, Pranavi Jagadeesan, Karla K. Frietze, Rulaiha Taylor, Grace L. Gao, Grant Gallagher, Joseph T. Nickels. Humanized monoacylglycerol acyltransferase 2 mice develop metabolic dysfunction-associated steatohepatitis. Journal of Lipid Research 2024; 65(12): 100695 doi: 10.1016/j.jlr.2024.100695
|
| 3 |
Sayed Obaidullah Aseem, Phillip B. Hylemon, Huiping Zhou. Bile Acids and Biliary Fibrosis. Cells 2023; 12(5): 792 doi: 10.3390/cells12050792
|
| 4 |
Rulaiha Taylor, Veronia Basaly, Bo Kong, Ill Yang, Anita M Brinker, Gina Capece, Anisha Bhattacharya, Zakiyah R Henry, Katherine Otersen, Zhenning Yang, Vik Meadows, Stephanie Mera, Laurie B Joseph, Peihong Zhou, Lauren M Aleksunes, Troy Roepke, Brian Buckley, Grace L Guo. Effects of therapeutically approved individual bile acids on the development of metabolic dysfunction-associated steatohepatitis a low bile acid mouse model. Toxicological Sciences 2024; 202(2): 179 doi: 10.1093/toxsci/kfae110
|
| 5 |
Wenkuan Li, Jawaher Abdullah Alamoudi, Nagsen Gautam, Devendra Kumar, Macro Olivera, Yeongjin Gwon, Sandeep Mukgerjee, Yazen Alnouti, Amal Santra. Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases. International Journal of Hepatology 2022; 2022: 1 doi: 10.1155/2022/5473752
|
| 6 |
Harry Sutton, Ronald J. Sokol, Binita M. Kamath. IBAT inhibitors in pediatric cholestatic liver diseases: Transformation on the horizon?. Hepatology 2025; 82(4): 985 doi: 10.1097/HEP.0000000000001032
|
| 7 |
A Current Understanding of Bile Acids in Chronic Liver Disease. Journal of Clinical and Experimental Hepatology 2022; 12(1): 155 doi: 10.1016/j.jceh.2021.08.017
|
| 8 |
Leon Deutsch, Alexandros Sotiridis, Boštjan Murovec, Janez Plavec, Igor Mekjavic, Tadej Debevec, Blaž Stres. Exercise and Interorgan Communication: Short-Term Exercise Training Blunts Differences in Consecutive Daily Urine 1H-NMR Metabolomic Signatures between Physically Active and Inactive Individuals. Metabolites 2022; 12(6): 473 doi: 10.3390/metabo12060473
|
| 9 |
Bandar D. Alrehaili. Unravelling the therapeutic landscape of bile acid-based therapies in gastrointestinal disorders. Saudi Journal of Gastroenterology 2024; 30(5): 283 doi: 10.4103/sjg.sjg_53_24
|
| 10 |
Rulaiha Taylor, Zhenning Yang, Zakiyah Henry, Gina Capece, Vik Meadows, Katherine Otersen, Veronia Basaly, Anisha Bhattacharya, Stephanie Mera, Peihong Zhou, Laurie Joseph, Ill Yang, Anita Brinker, Brian Buckley, Bo Kong, Grace L Guo. Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse model. Toxicological Sciences 2024; 199(2): 316 doi: 10.1093/toxsci/kfae029
|
| 11 |
Zakiyah R Henry, Syeda Maliha, Veronia Basaly, Zhenning Yang, Rulaiha E Taylor, Katherine Otersen, Vik Meadows, Daniel Rizzolo, Mary Stofan, Anisha Bhattacharya, Peihong Zhou, Anita Brinker, Ill Yang, Lanjing Zhang, Laurie B Joseph, Brian Buckley, Bo Kong, Grace L Guo. Ursodeoxycholic acid acts as an ileal FXR agonist in male mice with hepatic deficiency of FXR. eGastroenterology 2025; 3(3): e100227 doi: 10.1136/egastro-2025-100227
|
| 12 |
Ahmed Ghallab, Mattias Mandorfer, Guido Stirnimann, Joachim Geyer, Erik Lindström, Tom Luedde, Schalk van der Merwe, Jassin Rashidi-Alavijeh, Hartmut Schmidt, Saul J. Karpen, Peter Fickert, Michael Trauner, Jan G. Hengstler, Paul A. Dawson. Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitors. Journal of Hepatology 2025; 83(5): 1204 doi: 10.1016/j.jhep.2025.05.009
|
| 13 |
Gopanandan Parthasarathy, Harmeet Malhi, Jasmohan S. Bajaj. Therapeutic manipulation of the microbiome in liver disease. Hepatology 2024; doi: 10.1097/HEP.0000000000000987
|
| 14 |
Matthias Grimmler, Tobias Frömel, Angelique Masetto, Holger Müller, Tina Leber, Christoph Peter. Performance evaluation of enzymatic total bile acid (TBA) routine assays: systematic comparison of five fifth-generation TBA cycling methods and their individual bile acid recovery from HPLC-MS/MS reference. Clinical Chemistry and Laboratory Medicine (CCLM) 2025; 63(4): 753 doi: 10.1515/cclm-2024-1029
|
| 15 |
Jie Li, Xiaolong Lian, Baojian Li, Quhuan Ma, Lingling Yang, Guangmiao Gao, Tingmei Yin, Xiaoyan Fu, Yi Deng, Zhijun Yang, Xiujuan Yang. Pharmacodynamic material basis of licorice and mechanisms of modulating bile acid metabolism and gut microbiota in cisplatin-induced liver injury based on LC-MS and network pharmacology analysis. Journal of Ethnopharmacology 2025; 340: 119293 doi: 10.1016/j.jep.2024.119293
|
| 16 |
M. Schauermann, R. Wang, J. Pons-Kuehnemann, M.F. Hartmann, T. Remer, Y. Hua, A. Bereket, M. Wasniewska, M. Shmoish, Z. Hochberg, A. Gawlik, S.A. Wudy. Targeted quantitative analysis of urinary bile acids by liquid chromatography-tandem mass spectrometry: Method development and application to healthy and obese children. The Journal of Steroid Biochemistry and Molecular Biology 2025; 249: 106712 doi: 10.1016/j.jsbmb.2025.106712
|
| 17 |
Veronia Basaly, Zakiyah R. Henry, Rulaiha E. Taylor, Bo Kong, Ill Yang, Anita Brinker, Zhenning Yang, Peihong Zhou, Laurie B. Joseph, Lauren Aleksunes, Brian Buckley, Masahiko Negishi, Grace L. Guo. Mutation of PXR phosphorylation motif at Ser347 disrupts lipid and bile acid homeostasis in diet-induced metabolic dysfunction–associated steatohepatitis in mice. Drug Metabolism and Disposition 2026; 54(2): 100222 doi: 10.1016/j.dmd.2025.100222
|
| 18 |
Han Hu, Salim Jamil, Muhammad Bilal Azmat, Mohammed Alissa, Ghfren S. Aloraini, Amal A. Albati, Ahmed Al-Emam, Hesham M. Hassan. Tapentadol induces progressive hepatic damage via disrupting Hippo–YAP and Bile acid–FXR pathways: An Integrated Experimental and Computational Perspective. Tissue and Cell 2026; : 103362 doi: 10.1016/j.tice.2026.103362
|